332 related articles for article (PubMed ID: 17110602)
21. Higher frequency of abnormal serum angiopoietin-like protein 3 than abnormal cholesteryl ester transfer protein in Japanese hyperalphalipoproteinemic subjects.
Moon HD; Nakajima K; Kamiyama K; Takanashi K; Sakurabayashi I; Nagamine T
Clin Chim Acta; 2008 Dec; 398(1-2):99-104. PubMed ID: 18804459
[TBL] [Abstract][Full Text] [Related]
22. The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone.
Fugier C; Tousaint JJ; Prieur X; Plateroti M; Samarut J; Delerive P
J Biol Chem; 2006 Apr; 281(17):11553-9. PubMed ID: 16505486
[TBL] [Abstract][Full Text] [Related]
23. ANGPTL3 is a novel HDL component that regulates HDL function.
Yang L; Wang Y; Xu Y; Li K; Yin R; Zhang L; Wang D; Wei L; Lang J; Cheng Y; Wang L; Ke J; Zhao D
J Transl Med; 2024 Mar; 22(1):263. PubMed ID: 38462608
[TBL] [Abstract][Full Text] [Related]
24. Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity.
Fujimoto K; Koishi R; Shimizugawa T; Ando Y
Exp Anim; 2006 Jan; 55(1):27-34. PubMed ID: 16508209
[TBL] [Abstract][Full Text] [Related]
25. ANGPTL3 is part of the machinery causing dyslipidemia majorily via LPL inhibition in mastitis mice.
Xiao HB; Wang JY; Sun ZL
Exp Mol Pathol; 2017 Dec; 103(3):242-248. PubMed ID: 29104012
[TBL] [Abstract][Full Text] [Related]
26. Antisense oligonucleotide-mediated inhibition of angiopoietin-like protein 3 increases reverse cholesterol transport in mice.
Bell TA; Liu M; Donner AJ; Lee RG; Mullick AE; Crooke RM
J Lipid Res; 2021; 62():100101. PubMed ID: 34371033
[TBL] [Abstract][Full Text] [Related]
27. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase.
Shimizugawa T; Ono M; Shimamura M; Yoshida K; Ando Y; Koishi R; Ueda K; Inaba T; Minekura H; Kohama T; Furukawa H
J Biol Chem; 2002 Sep; 277(37):33742-8. PubMed ID: 12097324
[TBL] [Abstract][Full Text] [Related]
28. A novel endothelial-derived lipase that modulates HDL metabolism.
Jaye M; Lynch KJ; Krawiec J; Marchadier D; Maugeais C; Doan K; South V; Amin D; Perrone M; Rader DJ
Nat Genet; 1999 Apr; 21(4):424-8. PubMed ID: 10192396
[TBL] [Abstract][Full Text] [Related]
29. In Silico Description of the Direct Inhibition Mechanism of Endothelial Lipase by ANGPTL3.
Montavoci L; Ben Mariem O; Saporiti S; Laurenzi T; Palazzolo L; Ossoli AF; Guerrini U; Calabresi L; Eberini I
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542527
[TBL] [Abstract][Full Text] [Related]
30. Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3.
Pisciotta L; Favari E; Magnolo L; Simonelli S; Adorni MP; Sallo R; Fancello T; Zavaroni I; Ardigò D; Bernini F; Calabresi L; Franceschini G; Tarugi P; Calandra S; Bertolini S
Circ Cardiovasc Genet; 2012 Feb; 5(1):42-50. PubMed ID: 22062970
[TBL] [Abstract][Full Text] [Related]
31. Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes.
Shimamura M; Matsuda M; Kobayashi S; Ando Y; Ono M; Koishi R; Furukawa H; Makishima M; Shimomura I
Biochem Biophys Res Commun; 2003 Feb; 301(2):604-9. PubMed ID: 12565906
[TBL] [Abstract][Full Text] [Related]
32. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia.
Musunuru K; Pirruccello JP; Do R; Peloso GM; Guiducci C; Sougnez C; Garimella KV; Fisher S; Abreu J; Barry AJ; Fennell T; Banks E; Ambrogio L; Cibulskis K; Kernytsky A; Gonzalez E; Rudzicz N; Engert JC; DePristo MA; Daly MJ; Cohen JC; Hobbs HH; Altshuler D; Schonfeld G; Gabriel SB; Yue P; Kathiresan S
N Engl J Med; 2010 Dec; 363(23):2220-7. PubMed ID: 20942659
[TBL] [Abstract][Full Text] [Related]
33. The Potential of ANGPTL8 Antagonism to Simultaneously Reduce Triglyceride and Increase HDL-Cholesterol Plasma Levels.
Zhang R
Front Cardiovasc Med; 2021; 8():795370. PubMed ID: 34869703
[TBL] [Abstract][Full Text] [Related]
34. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events.
Miida T; Hirayama S
Curr Opin Lipidol; 2010 Feb; 21(1):70-5. PubMed ID: 19851103
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo.
Jin W; Millar JS; Broedl U; Glick JM; Rader DJ
J Clin Invest; 2003 Feb; 111(3):357-62. PubMed ID: 12569161
[TBL] [Abstract][Full Text] [Related]
36. Angiopoietin-Like Protein 4 Is a High-Density Lipoprotein (HDL) Component for HDL Metabolism and Function in Nondiabetic Participants and Type-2 Diabetic Patients.
Yang LY; Yu CG; Wang XH; Yuan SS; Zhang LJ; Lang JN; Zhao D; Feng YM
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645936
[TBL] [Abstract][Full Text] [Related]
37. Endothelial lipase promotes the catabolism of ApoB-containing lipoproteins.
Broedl UC; Maugeais C; Millar JS; Jin W; Moore RE; Fuki IV; Marchadier D; Glick JM; Rader DJ
Circ Res; 2004 Jun; 94(12):1554-61. PubMed ID: 15117821
[TBL] [Abstract][Full Text] [Related]
38. Atypical angiopoietin-like protein that regulates ANGPTL3.
Quagliarini F; Wang Y; Kozlitina J; Grishin NV; Hyde R; Boerwinkle E; Valenzuela DM; Murphy AJ; Cohen JC; Hobbs HH
Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19751-6. PubMed ID: 23150577
[TBL] [Abstract][Full Text] [Related]
39. Role of endothelial lipase in plasma HDL levels in a murine model of hypertriglyceridemia.
Tanaka H; Ishida T; Johnston TP; Yasuda T; Ueyama T; Kojima Y; Kundu RK; Quertermous T; Ishikawa Y; Hirata K
J Atheroscler Thromb; 2009 Aug; 16(4):327-38. PubMed ID: 19672025
[TBL] [Abstract][Full Text] [Related]
40. Undaria pinnatifida soluble fiber regulates Angptl3-LPL pathway to lessen hyperlipidemia in mice.
Xiao HB; Lu XY; Zhang HB; Sun ZL; Fang J
J Physiol Biochem; 2013 Dec; 69(4):719-25. PubMed ID: 23595961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
